Gemcitabine monotherapy (GEM) versus cisplatin-based chemotherapy in symptomatic advanced NSCLC: A prospective randomised comparison of symptom control

Autor:	D Strens, J. Vandebroek, W. Van Kerckhoven, R. Deman, K Deschepper, J.P D'Odemont, L Siemons, P. Van Den Brande, Johan Vansteenkiste, Kurt Vandeurzen, K. Nackaerts, N L Dams
Rok vydání:	2000
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty Cisplatin based chemotherapy business.industry Internal medicine medicine Symptom control business Gemcitabine medicine.drug
Zdroj:	Lung Cancer. 29:48
ISSN:	0169-5002
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::559d44155e276eb1bf178f4793f15217 https://doi.org/10.1016/s0169-5002(00)80156-7 Zobrazit plný text záznamu Full Text from ScienceDirect